Analysis of molecular fingerprint and virulence factors of Helicobacter pylori strains;Análise das impressões digitais de DNA e de fatores de virulência de linhagens de Helicobacter pylori

Arquivos de Gastroenterologia

Volumn 44, Issue 2, 2007, Pages 107-112

  Godoy, Anita P O ^a   Miranda, Maíra C B ^a   Paulino, Luciana C ^a   Mendonça, Sergio ^a   Ribeiro, Marcelo Lima ^a,b   Pedrazzoli Jr , José ^a  

^a UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^b Unidade Integrada de Farmacologia e Gastroenterologia   (Brazil)

Author keywords

Antigens; Bacterial; Bacterial proteins; DNA fingerprints; Helicobacter infections; Helicobacter pylori

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN; VIRULENCE FACTOR;

ARTICLE; DNA FINGERPRINTING; DUODENUM ULCER; GASTRITIS; GASTROESOPHAGEAL REFLUX; GENOTYPE; HELICOBACTER PYLORI; NONHUMAN; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; STOMACH ULCER;

EID: 35649017239     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032007000200004     Document Type: Article

References (62)

1. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 1992;20:5137-42.
2. Arents NL, Van Zwet AA, Thijs JC, Kooistra-Smid AM, Van Slochteren KR, Degener JE, Kleibeuker JH, Van Doorn LJ. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:2603-8.
3. Ashour AA, Collares GB, Mendes EN, De Gusmao VR, Queiroz DM, Magalhaes PP, De Carvalho AS, De Oliveira CA, Nogueira AM, Rocha GA, Rocha AM. iceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults. J Clin Microbiol. 2001;39:1746-50.
4. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of especific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995;270:17771-7.
5. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997;112:92-9.
6. Bickley J, Owen RJ, Fraser AG, Pounder RE. Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol. 1993;39:338-44.
7. Bjorkholm BM, Oh JD, Falk PG, Engstrand LG, Gordon JI. Genomics and proteomics converge on Helicobacter pylori. Curr Opin Microbiol. 2001;4:237-45.
8. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111-5.
9. Bukanov NO, Berg DE. Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638. Mol Microbiol. 1994;11:509-23.
10. Burucoa C, Lhomme V, Fauchere JL. Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis. J Clin Microbiol. 1999;37:4071-80.
11. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993;90:5791-5.
12. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 1992;267:10570-5.
13. Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 2003;63:951
14. Dong Q, O'sullivan M, Hall W, Herra C, Kean C, O'Morain C, Buckley M. Identification of a new segment involved in cagA 3′ region variation of Helicobacter pylori. FEMS Immunol Med Microbiol. 2002;33:51-5.
15. Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol. 1994;47:436-9.
16. Evans DG, Queiroz DM, Mendes EN, Evans DJ Jr. Helicobacter pylori cagA status and s and m alleles of vacA in isolates from individuals with a variety of H. pylori-associated gastric diseases. J Clin Microbiol. 1998;36:3435-7.
17. Fallone CA, Barkun AN, Friedman G, Mayrand S, Loo V, Beech R, Best L, Joseph L.. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal disease. Am J Gastroenterol. 2000;95:659-69.
18. Feldman M, Cryer B, McArthur KE, Huet BA, Lee E. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology. 1996;110:1043-52.
19. Forman DE, Coletta D, Kenny D, Kosowsky BD, Stoukides J, Rohrer M, Pastore JO. Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients. Arch Intern Med. 1991;151:2194-8.
20. Fox JG, Dewhirst FE, Fraser GJ, Paster BJ, Shames B, Murphy JC. Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol. 1994;32:1229-37.
21. Gatti LL, Fagundes-e-Souza EK, Leite KR, Bastos EL, Vicentini LR, Silva LC, Smith A, Payao SL. cagA vacA alelles and babA2 genotypes of Helicobacter pylori associated with gastric disease in Brazilian adult patients. Diagn Microbiol Infect Dis. 2005;51:231-5.
22. Gebert B, Fischer W, Haas R. Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol. 2004;152:205-20.
23. Glocker E, Lange C, Covacci A, Bereswill S, Kist M, Pahl HL. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun. 1998;66:2346-8.
24. Go MF, Chan KY, Versalovic J, Koeuth T, Graham DY, Lupski JR. Cluster analysis of Helicobacter pylori genomic DNA fingerprints suggests gastroduodenal disease-specific associations. scand J Gastroenterol. 1995;30:640-6.
25. Go MF, Kapur V, Graham DY, Musser JM. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol. 1996;178:3934-8.
26. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda C, Mendonça S, Pedrazzoli J Jr. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol. 2003;3:20
27. Gunn MC, Stephens JC, Stewart JA, Rathbone BJ, West KP. The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J Clin Pathol. 1998;51:761-4.
28. Han FC, Ng HC, Ho B. stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori. World J Gastroenterol. 2003 9:2021-4.
29. Ho SA, Hoyle JA, Lewis FA, Secker AD, Cross D, Mapstone NP, Dixon MF, Wyatt JI, Tompkins DS, Taylor GR. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol. 1991;29:2543-9.
30. Kidd M, Atherton JC, Lastovica AJ, Louw JA. Clustering of south African Helicobacter pylori isolates from peptic ulcer disease patients is demonstrated by repetitive extragenic palindromic-PCR fingerprinting. J Clin Microbiol. 2001;9:1833-9.
31. Kuipers EJ, Israel DA, Kusters JG, Gerrits MM, Weel J, van Der Ende A, van Der Hulst RW, With HP, Hook-Nikanne J, Thompson AS, Blaser MJ. Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis. 2000;181:273-82.
32. Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut.1997;41:277-80.
33. Loffeld RJ, Werdmuller BF, Kusters JG, Perez-Perez GI, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion. 2000;62:95-9.
34. Logan RP, Berg DE. Genetic diversity of Helicobacter pylori. Lancet. 1996;348:1462-3.
35. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-4.
36. Martins LC, Corvelo TC, Demachki Araujo MT, Assumpcao MB, Vilar SC, Freitas FB, Barbosa HP, Fecury AA, do Amaral RK, dos Santos SE. Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from North Brazil. Mem Inst Oswaldo Cruz. 2005;100:875-81.
37. Mendonça S, Ecclissato C, Sartori MS, Godoy APO, Guerzoni RA, Degger M, Pedrazzoli JJ. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter. 2000;5:79-83.
38. Morales-Espinosa R, Castillo-Rojas G, Gonzalez-Valencia G, Ponce de Leon S, Cravioto A, Atherton JC, Lopez-Vidal Y. Colonization of Mexican patients by multiple Helicobacter pylori strains with different vacA and cagA genotypes. J Clin Microbiol. 1999;37:3001-4.
39. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC, Bravo LE, Realpe JL, Plaisier AP, Quint WG, Ruiz B, Correa P, van Doorn LJ. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001;158:647-54.2001;54.
40. Pai R, Cover TL, Tarnawski AS. Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochem Biophys Res Commun. 1999;262:245-50.
41. Parsonnet J, Replogle M, Yang S, Hiatt R. seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. J Infect Dis. 1997;175:1240-2.
42. Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest. 1995;73:760-70.
43. Peters TM, Owen RJ, Slater E, Varea R, Teare EL, Saverymuttu S. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia. J Clin Pathol. 2001;54:219-23.
44. Queiroz DMM, Mendes EN, Rocha GA. Indicator medium for isolation of Campylobacter pylori. J Clin Microbiol. 1987;25:2378-9.
45. Queiroz DM, Rocha GA, Oliveira CA, Rocha AM, Santos A, Cabral MM, Nogueira AM. Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis. J Clin Microbiol. 2002;40:2849-53.
46. Ribeiro ML, Vitiello L, Miranda MC, Benvengo YH, Godoy AP, Mendonca S, Pedrazzoli J Jr. Clinical relevance of the cagA, vacA and iceA genotypes of Helicobacter pylori in Brazilian clinical isolates. FEMs Immunol Med Microbiol. 2003;36:181-5.
47. Ribeiro ML, Gerrits MM, Benvengo YH, Berning M, Godoy AP, Kuipers EJ, Mendonca S, Van Vliet AH, Pedrazzoli J Jr, Kusters JG. Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using Pcr-Rflp. FEMS Immunol Med Microbiol. 2004;40:57-61.
48. Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, Stremmel W. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol. 1998;36:944-8.
49. Saiki RK, Walsh PS, Levenson CH, Erlich HA. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad U S A. 1989;86:6230-4.
50. Salama N, Guillemin K, McDaniel TK, Sherlock G, Tompkins L, Falkow S. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci U S A. 2000;97:14668-73.
51. Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet. 2001;357:1738-42.
52. Segal ED, Falkow S, Tompkins LS. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc Natl Acad U S A. 1996;93:1259-64.
53. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994;179:1653-8.
54. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61:1799-809.
55. Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger PM, Boer W, Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998;115:58-66.
56. Van Doorn LJ, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R, De Boer W, Schneeberger PM, Correa P, Ng EK, Atherton J, Blaser MJ, Quint WG. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology. 1999;116:823-30.
57. Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, Perez-Perez GI, Halter SA, Rice TW, Blaser MJ, Richter JE. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50-7.
58. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998;3:241-53.
59. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999;37:2274-9.
60. Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF. Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol. 1998;51:55-61.
61. Willhite DC, Blanke ER. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell Microbiol. 2004;6:143-54.
62. Williams JG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 1990;18:6531-5.